A randomized, placebo-controlled, double-blind trial to evaluate efficacy and safety of Shen-Yuan-Dan capsules, a traditional Chinese medicine, for treatment of peri-procedure myocardial injury following percutaneous coronary intervention

• Main Authors: Xiang Li (Author), Ying Zhang (Author), Hong-Xu Liu (Author), Ju-Ju Shang (Author), Qi Zhou (Author), Ai-Yong Li (Author), Xiao-Lei Lai (Author), Wen-Long Xing (Author), Si-Han Jia (Author)
• Format: Book
• Published: Elsevier, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Peri-procedural myocardial injury (PMI) is a common complication of percutaneous coronary intervention (PCI), which cannot be entirely avoided using available treatments. The findings of earlier research have shown that Shen-Yuan-Dan (SYD) capsules, a traditional Chinese medicine, can po...